-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Initiates Coverage On Caribou Biosciences with Buy Rating, Announces Price Target of $13

Benzinga·02/02/2026 21:27:31
Listen to the news
Clear Street analyst Bill Maughan initiates coverage on Caribou Biosciences (NASDAQ:CRBU) with a Buy rating and announces Price Target of $13.